None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Males and females aged 60 years over at the screening examination 2) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
Exclusion criteria
Exclusion criteria: 1) Patients with a clinically significant disease requiring treatment (i.e., severe cardiovascular system, endocrine system, neuropsychiatric system, musculoskeletal inflammation, gastrointestinal disease, inflammatory disease, blood and tumor disease, etc.) 2) Patients who take medicine or health functional food for myofunction within a month prior to the screening examination 3) Patients with a history of antipsychotic medication use within 2 months prior to the screening examination 4)Patients who have participated in other clinical trials within 2 months prior to the screening examination 5)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Isokinetic muscular strength;Grip;Muscle mass | — |
Secondary
| Measure | Time frame |
|---|---|
| Short Physical Performance Battery;Muscle-related hormones;Composite score;Cytokines;Growth-related hormones;hs-CRP(high sensitive C reaction protein);Stress-related hormones;WHOQOL-BREF(World Health Organization Quality of Life-BREF) | — |
Countries
Korea, Republic of
Contacts
Chonbuk National University Hospital